143 related articles for article (PubMed ID: 21725799)
1. Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer.
Patil AG; D'Souza R; Dixit N; Damre A
Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):115-9. PubMed ID: 21725799
[TBL] [Abstract][Full Text] [Related]
2. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
3. Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.
Lumen AA; Li L; Li J; Ahmed Z; Meng Z; Owen A; Ellens H; Hidalgo IJ; Bentz J
PLoS One; 2013; 8(8):e69394. PubMed ID: 23976943
[TBL] [Abstract][Full Text] [Related]
4. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
5. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
7. Role of P-glycoprotein in distribution of rhodamine 123 into aqueous humor in rabbits.
Kajikawa T; Mishima HK; Murakami T; Takano M
Curr Eye Res; 1999 Mar; 18(3):240-6. PubMed ID: 10342379
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines.
Mukkavilli R; Jadhav G; Vangala S
Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222
[TBL] [Abstract][Full Text] [Related]
9. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of RP-HPLC-fluorescence method for quantitative determination of quinidine, a probe substrate for P-glycoprotein inhibition assay using Caco-2 cell monolayer.
Patil AG; Reddy D; D'Souza R; Damre A
Biomed Chromatogr; 2010 Jun; 24(6):620-5. PubMed ID: 19816852
[TBL] [Abstract][Full Text] [Related]
11. Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization.
Jain R; Majumdar S; Nashed Y; Pal D; Mitra AK
Mol Pharm; 2004; 1(4):290-9. PubMed ID: 15981588
[TBL] [Abstract][Full Text] [Related]
12. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
Dahan A; Sabit H; Amidon GL
AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
[TBL] [Abstract][Full Text] [Related]
13. Model analysis of the concentration-dependent permeability of P-gp substrates.
Tachibana T; Kitamura S; Kato M; Mitsui T; Shirasaka Y; Yamashita S; Sugiyama Y
Pharm Res; 2010 Mar; 27(3):442-6. PubMed ID: 20135207
[TBL] [Abstract][Full Text] [Related]
14. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of furanocoumarin derivatives in Kampo extract medicines on P-glycoprotein at the blood-brain barrier.
Iwanaga K; Yoneda S; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
Biol Pharm Bull; 2011; 34(8):1246-51. PubMed ID: 21804213
[TBL] [Abstract][Full Text] [Related]
16. Phorbol 12-myristate 13-acetate inhibits P-glycoprotein-mediated efflux of digoxin in MDCKII-MDR1 and Caco-2 cell monolayer models.
Li YH; Bi HC; Huang L; Jin J; Zhong GP; Zhou XN; Huang M
Acta Pharmacol Sin; 2014 Feb; 35(2):283-91. PubMed ID: 24362330
[TBL] [Abstract][Full Text] [Related]
17. Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine.
Duvvuri S; Gandhi MD; Mitra AK
Curr Eye Res; 2003 Dec; 27(6):345-53. PubMed ID: 14704918
[TBL] [Abstract][Full Text] [Related]
18. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
Parasrampuria DA; Lantz MV; Benet LZ
Pharm Res; 2001 Jan; 18(1):39-44. PubMed ID: 11336351
[TBL] [Abstract][Full Text] [Related]
19. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein.
Keogh JP; Kunta JR
Eur J Pharm Sci; 2006 Apr; 27(5):543-54. PubMed ID: 16406207
[TBL] [Abstract][Full Text] [Related]
20. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]